Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Midtvedt, K.
Right arrow Articles by Hartmann, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Midtvedt, K.
Right arrow Articles by Hartmann, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 1166-1169
© 2002 European Renal Association-European Dialysis and Transplant Association

Editorial Comments

Hypertension after kidney transplantation: are treatment guidelines emerging?

Karsten Midtvedt and Anders Hartmann

Medical Department, Nephrology Section, Rikshospitalet University Hospital, Oslo, Norway

Keywords: hypertension; renal transplantation; treatment guidelines

The first 150 words of the full text of this article appear below.

Introduction

Hypertension after renal transplantation is a strong predictor of patient and graft survival, but European guidelines for treatment of post-transplant hypertension have not yet been put forward. However, with the present knowledge, including data from recent intervention studies, there is a basis for future therapy guidelines. Here we address some important aspects of hypertension and its treatment after kidney transplantation.

Definition of post-transplant hypertension

In transplant recipients, hypertension is usually defined as blood pressure >140/90 mmHg or likewise if a patient is treated with antihypertensive drugs [1,2]. A cut-off at 150/90 mmHg has also been proposed [3]. We prefer the first definition, which is probably the most widely accepted cut-off value for primary hypertension in the general population [4]. Some centres use the blood pressure criteria of the World Health Organization/International Society of Hypertension (>130/85 mmHg) [5].

Incidence and pathophysiology of post-transplant hypertension

Prior to the introduction of cyclosporine as . . . [Full Text of this Article]

Impact of post-transplant hypertension

Drug treatment of hypertension after transplantation

Left ventricular hypertrophy and combination therapy

Treatment goals

Summary


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CJASNHome page
A. Djamali, M. Samaniego, B. Muth, R. Muehrer, R. M. Hofmann, J. Pirsch, A. Howard, G. Mourad, and B. N. Becker
Medical Care of Kidney Transplant Recipients after the First Posttransplant Year
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 623 - 640.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. S. Zaltzman, M. Nash, R. Chiu, and R. Prasad
The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy-proven allograft nephropathy
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 940 - 944.
[Abstract] [Full Text] [PDF]